Novel motif:136: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:16, 9 September 2013
name: | motif136_GTCTGCGTCTCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 7.522400e-16 |
GO:0048266 | behavioral response to pain | 8.549039e-13 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 7.971425e-11 |
GO:0045994 | positive regulation of translational initiation by iron | 1.075178e-10 |
GO:0002037 | negative regulation of L-glutamate transport | 1.075178e-10 |
GO:0003009 | skeletal muscle contraction | 2.722083e-10 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 3.747504e-10 |
GO:0006447 | regulation of translational initiation by iron | 5.661582e-10 |
GO:0050881 | musculoskeletal movement | 9.332360e-10 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 2.504013e-9 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 2.756526e-9 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 6.929905e-9 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 8.475426e-9 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.124418e-8 |
GO:0002922 | positive regulation of humoral immune response | 1.656191e-8 |
GO:0051956 | negative regulation of amino acid transport | 1.828583e-8 |
GO:0030225 | macrophage differentiation | 2.354672e-8 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 2.585420e-8 |
GO:0002920 | regulation of humoral immune response | 3.323776e-8 |
GO:0044236 | multicellular organismal metabolic process | 5.632153e-8 |
GO:0055093 | response to hyperoxia | 6.514266e-8 |
GO:0008625 | induction of apoptosis via death domain receptors | 7.068589e-8 |
GO:0010765 | positive regulation of sodium ion transport | 9.324983e-8 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 9.755443e-8 |
GO:0006958 | complement activation, classical pathway | 1.062444e-7 |
GO:0006956 | complement activation | 1.423207e-7 |
GO:0045662 | negative regulation of myoblast differentiation | 2.409421e-7 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 2.486069e-7 |
GO:0043973 | histone H3-K4 acetylation | 2.486069e-7 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 2.486069e-7 |
GO:0060033 | anatomical structure regression | 2.917756e-7 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 3.001939e-7 |
GO:0045835 | negative regulation of meiosis | 3.986964e-7 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 4.250076e-7 |
GO:0030574 | collagen catabolic process | 4.295102e-7 |
GO:0002573 | myeloid leukocyte differentiation | 4.764832e-7 |
GO:0010866 | regulation of triglyceride biosynthetic process | 5.083788e-7 |
GO:0045661 | regulation of myoblast differentiation | 5.174837e-7 |
GO:0090207 | regulation of triglyceride metabolic process | 5.795036e-7 |
GO:0045112 | integrin biosynthetic process | 6.262775e-7 |
GO:0006959 | humoral immune response | 6.467553e-7 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 6.676489e-7 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 7.394014e-7 |
GO:0046108 | uridine metabolic process | 7.394014e-7 |
GO:0032929 | negative regulation of superoxide anion generation | 8.104019e-7 |
GO:0010625 | positive regulation of Schwann cell proliferation | 8.626079e-7 |
GO:0044243 | multicellular organismal catabolic process | 8.724804e-7 |
GO:0060319 | primitive erythrocyte differentiation | 1.106258e-6 |
GO:0002575 | basophil chemotaxis | 1.106258e-6 |
GO:0048771 | tissue remodeling | 1.157032e-6 |
GO:0048705 | skeletal system morphogenesis | 1.286591e-6 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.407292e-6 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.435164e-6 |
GO:0002678 | positive regulation of chronic inflammatory response | 1.453326e-6 |
GO:0045760 | positive regulation of action potential | 1.471725e-6 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.476664e-6 |
GO:0035441 | cell migration involved in vasculogenesis | 1.987525e-6 |
GO:0071347 | cellular response to interleukin-1 | 2.030038e-6 |
GO:0001300 | chronological cell aging | 2.396258e-6 |
GO:0030852 | regulation of granulocyte differentiation | 2.431516e-6 |
GO:0032963 | collagen metabolic process | 2.566136e-6 |
GO:0045948 | positive regulation of translational initiation | 2.588982e-6 |
GO:0030224 | monocyte differentiation | 2.768941e-6 |
GO:0051216 | cartilage development | 2.865795e-6 |
GO:0002676 | regulation of chronic inflammatory response | 3.126844e-6 |
GO:0030826 | regulation of cGMP biosynthetic process | 3.244845e-6 |
GO:0051023 | regulation of immunoglobulin secretion | 3.639656e-6 |
GO:0003417 | growth plate cartilage development | 3.756841e-6 |
GO:0035304 | regulation of protein dephosphorylation | 3.992101e-6 |
GO:0030100 | regulation of endocytosis | 4.028738e-6 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 4.348303e-6 |
GO:0002036 | regulation of L-glutamate transport | 4.610084e-6 |
GO:0002230 | positive regulation of defense response to virus by host | 5.049448e-6 |
GO:0045649 | regulation of macrophage differentiation | 5.075987e-6 |
GO:0050830 | defense response to Gram-positive bacterium | 5.254720e-6 |
GO:0003416 | endochondral bone growth | 5.724888e-6 |
GO:0051971 | positive regulation of transmission of nerve impulse | 5.771541e-6 |
GO:0001894 | tissue homeostasis | 6.501925e-6 |
GO:0035356 | cellular triglyceride homeostasis | 6.929625e-6 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 7.213027e-6 |
GO:0046849 | bone remodeling | 7.228061e-6 |
GO:0090279 | regulation of calcium ion import | 7.430299e-6 |
GO:0031646 | positive regulation of neurological system process | 7.573561e-6 |
GO:0035725 | sodium ion transmembrane transport | 8.173506e-6 |
GO:0006540 | glutamate decarboxylation to succinate | 8.388227e-6 |
GO:0050806 | positive regulation of synaptic transmission | 8.623676e-6 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 1.027815e-5 |
GO:0048265 | response to pain | 1.075568e-5 |
GO:0042391 | regulation of membrane potential | 1.102926e-5 |
GO:0002028 | regulation of sodium ion transport | 1.107040e-5 |
GO:0035305 | negative regulation of dephosphorylation | 1.293095e-5 |
GO:0045651 | positive regulation of macrophage differentiation | 1.330163e-5 |
GO:0060696 | regulation of phospholipid catabolic process | 1.360186e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 1.368547e-5 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.387286e-5 |
GO:0043982 | histone H4-K8 acetylation | 1.395763e-5 |
GO:0043981 | histone H4-K5 acetylation | 1.395763e-5 |
GO:0072277 | metanephric glomerular capillary formation | 1.404737e-5 |
GO:0046684 | response to pyrethroid | 1.522882e-5 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.535217e-5 |
GO:0035272 | exocrine system development | 1.567374e-5 |
GO:0007422 | peripheral nervous system development | 1.638115e-5 |
GO:0035036 | sperm-egg recognition | 1.647962e-5 |
GO:0006707 | cholesterol catabolic process | 1.701812e-5 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 1.728507e-5 |
GO:0002675 | positive regulation of acute inflammatory response | 1.769565e-5 |
GO:0090197 | positive regulation of chemokine secretion | 1.849802e-5 |
GO:0032754 | positive regulation of interleukin-5 production | 1.856757e-5 |
GO:0007296 | vitellogenesis | 1.864182e-5 |
GO:0043271 | negative regulation of ion transport | 1.931487e-5 |
GO:0034502 | protein localization to chromosome | 1.975542e-5 |
GO:0035306 | positive regulation of dephosphorylation | 1.991649e-5 |
GO:0001508 | regulation of action potential | 2.598686e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 2.606281e-5 |
GO:0002316 | follicular B cell differentiation | 2.766017e-5 |
GO:0070079 | histone H4-R3 demethylation | 2.805420e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.805420e-5 |
GO:0070078 | histone H3-R2 demethylation | 2.805420e-5 |
GO:0035117 | embryonic arm morphogenesis | 2.903728e-5 |
GO:0016337 | cell-cell adhesion | 2.964604e-5 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 3.060556e-5 |
GO:0051798 | positive regulation of hair follicle development | 3.174250e-5 |
GO:0060688 | regulation of morphogenesis of a branching structure | 3.177141e-5 |
GO:0045926 | negative regulation of growth | 3.189472e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 3.200927e-5 |
GO:0060591 | chondroblast differentiation | 3.203771e-5 |
GO:0071585 | detoxification of cadmium ion | 3.264995e-5 |
GO:0060561 | apoptosis involved in morphogenesis | 3.311787e-5 |
GO:0002673 | regulation of acute inflammatory response | 3.417763e-5 |
GO:0071670 | smooth muscle cell chemotaxis | 3.617574e-5 |
GO:0060981 | cell migration involved in coronary angiogenesis | 3.617574e-5 |
GO:0060977 | coronary vasculature morphogenesis | 3.670868e-5 |
GO:0039020 | pronephric nephron tubule development | 3.819140e-5 |
GO:0035565 | regulation of pronephros size | 3.819140e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 3.819140e-5 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 4.337298e-5 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 4.352238e-5 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 4.454909e-5 |
GO:0007159 | leukocyte cell-cell adhesion | 4.651787e-5 |
GO:0090196 | regulation of chemokine secretion | 4.713301e-5 |
GO:0009988 | cell-cell recognition | 4.801379e-5 |
GO:0060349 | bone morphogenesis | 4.968972e-5 |
GO:0048167 | regulation of synaptic plasticity | 4.980550e-5 |
GO:0052565 | response to defense-related host nitric oxide production | 5.172985e-5 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 5.438563e-5 |
GO:0060754 | positive regulation of mast cell chemotaxis | 5.489578e-5 |
GO:0005984 | disaccharide metabolic process | 5.504230e-5 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.620597e-5 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 5.822904e-5 |
GO:0042088 | T-helper 1 type immune response | 6.107849e-5 |
GO:0071258 | cellular response to gravity | 6.148238e-5 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 6.148238e-5 |
GO:0061044 | negative regulation of vascular wound healing | 6.148238e-5 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 6.148238e-5 |
GO:0045721 | negative regulation of gluconeogenesis | 6.176447e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 6.212092e-5 |
GO:0071803 | positive regulation of podosome assembly | 6.501432e-5 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 6.749871e-5 |
GO:0006972 | hyperosmotic response | 6.849706e-5 |
GO:0015696 | ammonium transport | 7.030656e-5 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 7.363607e-5 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 7.530817e-5 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 7.558826e-5 |
GO:0045684 | positive regulation of epidermis development | 7.627874e-5 |
GO:0043088 | regulation of Cdc42 GTPase activity | 7.627874e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 7.712811e-5 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 7.968894e-5 |
GO:0030099 | myeloid cell differentiation | 8.363688e-5 |
GO:0007612 | learning | 8.690512e-5 |
GO:0018125 | peptidyl-cysteine methylation | 8.846764e-5 |
GO:0002712 | regulation of B cell mediated immunity | 8.888760e-5 |
GO:0001649 | osteoblast differentiation | 8.992037e-5 |
GO:0071168 | protein localization to chromatin | 9.220285e-5 |
GO:0045453 | bone resorption | 9.584711e-5 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 9.878664e-5 |
GO:0071456 | cellular response to hypoxia | 9.905880e-5 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.015599e-4 |
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | 1.017937e-4 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.018877e-4 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.019970e-4 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.027888e-4 |
GO:0072376 | protein activation cascade | 1.029498e-4 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.036811e-4 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 1.071015e-4 |
GO:0010959 | regulation of metal ion transport | 1.079568e-4 |
GO:0060291 | long-term synaptic potentiation | 1.085874e-4 |
GO:0060627 | regulation of vesicle-mediated transport | 1.095791e-4 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 1.118712e-4 |
GO:0051701 | interaction with host | 1.181871e-4 |
GO:0006538 | glutamate catabolic process | 1.188146e-4 |
GO:0060348 | bone development | 1.206357e-4 |
GO:0090281 | negative regulation of calcium ion import | 1.214602e-4 |
GO:0071584 | negative regulation of zinc ion import | 1.214602e-4 |
GO:0051497 | negative regulation of stress fiber assembly | 1.226714e-4 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 1.234494e-4 |
GO:0002274 | myeloid leukocyte activation | 1.268550e-4 |
GO:0006534 | cysteine metabolic process | 1.270946e-4 |
GO:0002250 | adaptive immune response | 1.288963e-4 |
GO:0006998 | nuclear envelope organization | 1.327589e-4 |
GO:0042117 | monocyte activation | 1.359231e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.378858e-4 |
GO:0032571 | response to vitamin K | 1.384215e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.428750e-4 |
GO:0034765 | regulation of ion transmembrane transport | 1.464829e-4 |
GO:0032959 | inositol trisphosphate biosynthetic process | 1.515388e-4 |
GO:0060087 | relaxation of vascular smooth muscle | 1.553135e-4 |
GO:0044319 | wound healing, spreading of cells | 1.565453e-4 |
GO:0045670 | regulation of osteoclast differentiation | 1.613572e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.666213e-4 |
GO:0001933 | negative regulation of protein phosphorylation | 1.679703e-4 |
GO:0070482 | response to oxygen levels | 1.680023e-4 |
GO:0019048 | virus-host interaction | 1.708925e-4 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.713694e-4 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.713694e-4 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.713694e-4 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.713694e-4 |
GO:0016226 | iron-sulfur cluster assembly | 1.733594e-4 |
GO:0046732 | active induction of host immune response by virus | 1.757880e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.764932e-4 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.791136e-4 |
GO:0035771 | interleukin-4-mediated signaling pathway | 1.888063e-4 |
GO:0061037 | negative regulation of cartilage development | 1.955974e-4 |
GO:0046730 | induction of host immune response by virus | 1.981065e-4 |
GO:0043269 | regulation of ion transport | 1.981109e-4 |
GO:0071034 | CUT catabolic process | 2.040942e-4 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 2.040942e-4 |
GO:0015747 | urate transport | 2.042891e-4 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 2.149915e-4 |
GO:0007435 | salivary gland morphogenesis | 2.152127e-4 |
GO:0001502 | cartilage condensation | 2.193421e-4 |
GO:0003073 | regulation of systemic arterial blood pressure | 2.217906e-4 |
GO:0005989 | lactose biosynthetic process | 2.237728e-4 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 2.382025e-4 |
GO:0071316 | cellular response to nicotine | 2.404254e-4 |
GO:0002883 | regulation of hypersensitivity | 2.404563e-4 |
GO:0019228 | regulation of action potential in neuron | 2.413770e-4 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 2.423973e-4 |
GO:0052200 | response to host defenses | 2.494593e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 2.503502e-4 |
GO:0045918 | negative regulation of cytolysis | 2.515915e-4 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.607233e-4 |
GO:0048569 | post-embryonic organ development | 2.642152e-4 |
GO:0048873 | homeostasis of number of cells within a tissue | 2.646193e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 2.742226e-4 |
GO:0061157 | mRNA destabilization | 2.742226e-4 |
GO:0043060 | meiotic metaphase I plate congression | 2.755799e-4 |
GO:0051324 | prophase | 2.783953e-4 |
GO:0001569 | patterning of blood vessels | 2.808703e-4 |
GO:0010872 | regulation of cholesterol esterification | 2.845856e-4 |
GO:0043983 | histone H4-K12 acetylation | 2.849631e-4 |
GO:0019226 | transmission of nerve impulse | 2.872664e-4 |
GO:0035308 | negative regulation of protein dephosphorylation | 2.931081e-4 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 2.937607e-4 |
GO:2000273 | positive regulation of receptor activity | 2.957704e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 2.974223e-4 |
GO:0015914 | phospholipid transport | 3.001904e-4 |
GO:0060020 | Bergmann glial cell differentiation | 3.038538e-4 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.053425e-4 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 3.141084e-4 |
GO:0046886 | positive regulation of hormone biosynthetic process | 3.173342e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 3.186790e-4 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 3.296321e-4 |
GO:0032958 | inositol phosphate biosynthetic process | 3.355765e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 3.368609e-4 |
GO:0070345 | negative regulation of fat cell proliferation | 3.521718e-4 |
GO:0008050 | female courtship behavior | 3.521718e-4 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 3.521718e-4 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 3.559140e-4 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.633378e-4 |
GO:0008298 | intracellular mRNA localization | 3.676896e-4 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 3.710786e-4 |
GO:0032900 | negative regulation of neurotrophin production | 3.710786e-4 |
GO:0032244 | positive regulation of nucleoside transport | 3.710786e-4 |
GO:0032462 | regulation of protein homooligomerization | 3.732147e-4 |
GO:0007338 | single fertilization | 3.805929e-4 |
GO:0001654 | eye development | 3.846828e-4 |
GO:0003333 | amino acid transmembrane transport | 3.897767e-4 |
GO:0034389 | lipid particle organization | 3.950326e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 3.965293e-4 |
GO:0070483 | detection of hypoxia | 3.973934e-4 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 4.032777e-4 |
GO:0007161 | calcium-independent cell-matrix adhesion | 4.032777e-4 |
GO:0072236 | metanephric loop of Henle development | 4.040828e-4 |
GO:0072329 | monocarboxylic acid catabolic process | 4.056302e-4 |
GO:0050804 | regulation of synaptic transmission | 4.089790e-4 |
GO:0040040 | thermosensory behavior | 4.092167e-4 |
GO:0001503 | ossification | 4.104718e-4 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.169941e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 4.226973e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.229404e-4 |
GO:0071312 | cellular response to alkaloid | 4.251770e-4 |
GO:0006105 | succinate metabolic process | 4.304918e-4 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 4.331912e-4 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.344030e-4 |
GO:0007339 | binding of sperm to zona pellucida | 4.465337e-4 |
GO:0033700 | phospholipid efflux | 4.492300e-4 |
GO:0001501 | skeletal system development | 4.508340e-4 |
GO:0051899 | membrane depolarization | 4.511175e-4 |
GO:0021523 | somatic motor neuron differentiation | 4.514978e-4 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 4.547028e-4 |
GO:0042552 | myelination | 4.569812e-4 |
GO:0050764 | regulation of phagocytosis | 4.569957e-4 |
GO:0048871 | multicellular organismal homeostasis | 4.759293e-4 |
GO:0035524 | proline transmembrane transport | 4.807488e-4 |
GO:0035303 | regulation of dephosphorylation | 4.857445e-4 |
GO:0032800 | receptor biosynthetic process | 4.945970e-4 |
GO:0010669 | epithelial structure maintenance | 5.275958e-4 |
GO:0031017 | exocrine pancreas development | 5.291726e-4 |
GO:0048671 | negative regulation of collateral sprouting | 5.483069e-4 |
GO:0045936 | negative regulation of phosphate metabolic process | 5.602086e-4 |
GO:0046325 | negative regulation of glucose import | 5.654834e-4 |
GO:0050957 | equilibrioception | 5.696896e-4 |
GO:0045986 | negative regulation of smooth muscle contraction | 5.732237e-4 |
GO:0001843 | neural tube closure | 5.848691e-4 |
GO:0002885 | positive regulation of hypersensitivity | 5.942742e-4 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 5.988649e-4 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 6.084390e-4 |
GO:0051969 | regulation of transmission of nerve impulse | 6.114722e-4 |
GO:0009062 | fatty acid catabolic process | 6.163983e-4 |
GO:0045123 | cellular extravasation | 6.244986e-4 |
GO:0007184 | SMAD protein import into nucleus | 6.327971e-4 |
GO:0051797 | regulation of hair follicle development | 6.404165e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 6.505334e-4 |
GO:0030260 | entry into host cell | 6.565039e-4 |
GO:0006873 | cellular ion homeostasis | 6.623102e-4 |
GO:0072239 | metanephric glomerulus vasculature development | 6.839479e-4 |
GO:0044154 | histone H3-K14 acetylation | 7.039473e-4 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 7.310352e-4 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 7.374390e-4 |
GO:0046512 | sphingosine biosynthetic process | 7.454277e-4 |
GO:2000210 | positive regulation of anoikis | 7.614568e-4 |
GO:0072089 | stem cell proliferation | 7.614568e-4 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 7.661665e-4 |
GO:0048703 | embryonic viscerocranium morphogenesis | 7.669857e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 7.674046e-4 |
GO:0042538 | hyperosmotic salinity response | 7.674241e-4 |
GO:0007621 | negative regulation of female receptivity | 7.674241e-4 |
GO:0014013 | regulation of gliogenesis | 7.774334e-4 |
GO:0030449 | regulation of complement activation | 7.788998e-4 |
GO:0050765 | negative regulation of phagocytosis | 7.910245e-4 |
GO:0014020 | primary neural tube formation | 8.091173e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 8.092506e-4 |
GO:0032425 | positive regulation of mismatch repair | 8.092506e-4 |
GO:0050766 | positive regulation of phagocytosis | 8.242057e-4 |
GO:0051588 | regulation of neurotransmitter transport | 8.359510e-4 |
GO:0032928 | regulation of superoxide anion generation | 8.474692e-4 |
GO:0060606 | tube closure | 8.652621e-4 |
GO:0070489 | T cell aggregation | 8.760459e-4 |
GO:0031329 | regulation of cellular catabolic process | 8.889266e-4 |
GO:0055082 | cellular chemical homeostasis | 8.941947e-4 |
GO:0048568 | embryonic organ development | 9.132523e-4 |
GO:0050729 | positive regulation of inflammatory response | 9.184428e-4 |
GO:0007431 | salivary gland development | 9.372641e-4 |
GO:0072104 | glomerular capillary formation | 9.448152e-4 |
GO:0006268 | DNA unwinding involved in replication | 9.448152e-4 |
GO:0051932 | synaptic transmission, GABAergic | 9.576429e-4 |
GO:0032074 | negative regulation of nuclease activity | 9.576429e-4 |
GO:0060249 | anatomical structure homeostasis | 9.797063e-4 |
GO:0006670 | sphingosine metabolic process | 1.000651e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.006179e-3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.022564e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 1.022564e-3 |
GO:0031063 | regulation of histone deacetylation | 1.057519e-3 |
GO:2000438 | negative regulation of monocyte extravasation | 1.068205e-3 |
GO:0080154 | regulation of fertilization | 1.068205e-3 |
GO:0035723 | interleukin-15-mediated signaling pathway | 1.068205e-3 |
GO:0035724 | CD24 biosynthetic process | 1.068205e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 1.069658e-3 |
GO:0071731 | response to nitric oxide | 1.078559e-3 |
GO:0043966 | histone H3 acetylation | 1.094864e-3 |
GO:0035136 | forelimb morphogenesis | 1.094864e-3 |
GO:0015816 | glycine transport | 1.104537e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1.107593e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.130820e-3 |
GO:0010172 | embryonic body morphogenesis | 1.139069e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 1.167589e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 1.168537e-3 |
GO:0072234 | metanephric nephron tubule development | 1.180482e-3 |
GO:0072488 | ammonium transmembrane transport | 1.185812e-3 |
GO:0042634 | regulation of hair cycle | 1.186742e-3 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.196978e-3 |
GO:0007128 | meiotic prophase I | 1.208296e-3 |
GO:0007626 | locomotory behavior | 1.210647e-3 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.211357e-3 |
GO:0006012 | galactose metabolic process | 1.224486e-3 |
GO:0030902 | hindbrain development | 1.240109e-3 |
GO:0030166 | proteoglycan biosynthetic process | 1.240409e-3 |
GO:0043547 | positive regulation of GTPase activity | 1.248736e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.287364e-3 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 1.291738e-3 |
GO:0035854 | eosinophil fate commitment | 1.297869e-3 |
GO:0030222 | eosinophil differentiation | 1.297869e-3 |
GO:0072355 | histone H3-T3 phosphorylation | 1.311598e-3 |
GO:0042780 | tRNA 3'-end processing | 1.311598e-3 |
GO:0070141 | response to UV-A | 1.331349e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.333874e-3 |
GO:0019087 | transformation of host cell by virus | 1.342194e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.348336e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.373946e-3 |
GO:0048592 | eye morphogenesis | 1.378026e-3 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1.443806e-3 |
GO:0007402 | ganglion mother cell fate determination | 1.464831e-3 |
GO:0006657 | CDP-choline pathway | 1.476406e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.516215e-3 |
GO:0040020 | regulation of meiosis | 1.552238e-3 |
GO:0008366 | axon ensheathment | 1.567070e-3 |
GO:0048593 | camera-type eye morphogenesis | 1.573171e-3 |
GO:0046588 | negative regulation of calcium-dependent cell-cell adhesion | 1.623105e-3 |
GO:0051890 | regulation of cardioblast differentiation | 1.629375e-3 |
GO:0050773 | regulation of dendrite development | 1.636743e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.636867e-3 |
GO:2000346 | negative regulation of hepatocyte proliferation | 1.702271e-3 |
GO:2000639 | negative regulation of SREBP-mediated signaling pathway | 1.702271e-3 |
GO:0046208 | spermine catabolic process | 1.706033e-3 |
GO:0043117 | positive regulation of vascular permeability | 1.740462e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.743659e-3 |
GO:0072054 | renal outer medulla development | 1.760115e-3 |
GO:0072053 | renal inner medulla development | 1.760115e-3 |
GO:0045143 | homologous chromosome segregation | 1.763469e-3 |
GO:0007156 | homophilic cell adhesion | 1.771981e-3 |
GO:0045116 | protein neddylation | 1.792393e-3 |
GO:0060896 | neural plate pattern specification | 1.799626e-3 |
GO:0060710 | chorio-allantoic fusion | 1.814576e-3 |
GO:0060221 | retinal rod cell differentiation | 1.818505e-3 |
GO:0070255 | regulation of mucus secretion | 1.818505e-3 |
GO:0043932 | ossification involved in bone remodeling | 1.875720e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 1.898923e-3 |
GO:2000744 | positive regulation of anterior head development | 1.912019e-3 |
GO:0060018 | astrocyte fate commitment | 1.945914e-3 |
GO:0045807 | positive regulation of endocytosis | 1.989434e-3 |
GO:0010954 | positive regulation of protein processing | 1.989866e-3 |
GO:0046520 | sphingoid biosynthetic process | 1.996238e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 2.011284e-3 |
GO:0072080 | nephron tubule development | 2.051187e-3 |
GO:0050886 | endocrine process | 2.099449e-3 |
GO:0002637 | regulation of immunoglobulin production | 2.103424e-3 |
GO:0043009 | chordate embryonic development | 2.108952e-3 |
GO:0071453 | cellular response to oxygen levels | 2.111495e-3 |
GO:0072170 | metanephric tubule development | 2.116843e-3 |
GO:0006706 | steroid catabolic process | 2.120281e-3 |
GO:0045924 | regulation of female receptivity | 2.150978e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 2.194894e-3 |
GO:0072181 | mesonephric duct formation | 2.208000e-3 |
GO:0070672 | response to interleukin-15 | 2.215097e-3 |
GO:0021569 | rhombomere 3 development | 2.215097e-3 |
GO:0060215 | primitive hemopoiesis | 2.248271e-3 |
GO:0060976 | coronary vasculature development | 2.253561e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 2.253561e-3 |
GO:0007389 | pattern specification process | 2.255641e-3 |
GO:0000726 | non-recombinational repair | 2.272007e-3 |
GO:0060973 | cell migration involved in heart development | 2.275577e-3 |
GO:0003218 | cardiac left ventricle formation | 2.321920e-3 |
GO:0021533 | cell differentiation in hindbrain | 2.331371e-3 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 2.343206e-3 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 2.343206e-3 |
GO:0030277 | maintenance of gastrointestinal epithelium | 2.368286e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 2.380856e-3 |
GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure | 2.395682e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.397247e-3 |
GO:0016064 | immunoglobulin mediated immune response | 2.406660e-3 |
GO:0033120 | positive regulation of RNA splicing | 2.419741e-3 |
GO:0060040 | retinal bipolar neuron differentiation | 2.422793e-3 |
GO:0031065 | positive regulation of histone deacetylation | 2.438545e-3 |
GO:0048745 | smooth muscle tissue development | 2.463698e-3 |
GO:0071593 | lymphocyte aggregation | 2.475070e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 2.502396e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 2.507656e-3 |
GO:0060350 | endochondral bone morphogenesis | 2.584633e-3 |
GO:0048634 | regulation of muscle organ development | 2.594532e-3 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 2.632187e-3 |
GO:0070555 | response to interleukin-1 | 2.641871e-3 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 2.689981e-3 |
GO:0045637 | regulation of myeloid cell differentiation | 2.703271e-3 |
GO:0021797 | forebrain anterior/posterior pattern specification | 2.706935e-3 |
GO:0001666 | response to hypoxia | 2.744549e-3 |
GO:0019725 | cellular homeostasis | 2.756611e-3 |
GO:0060133 | somatotropin secreting cell development | 2.765426e-3 |
GO:0001974 | blood vessel remodeling | 2.779751e-3 |
GO:0031099 | regeneration | 2.796024e-3 |
GO:0016075 | rRNA catabolic process | 2.823139e-3 |
GO:0060047 | heart contraction | 2.898128e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 2.916134e-3 |
GO:0035295 | tube development | 2.920707e-3 |
GO:0019233 | sensory perception of pain | 3.034451e-3 |
GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 3.038199e-3 |
GO:0031022 | nuclear migration along microfilament | 3.084800e-3 |
GO:0018208 | peptidyl-proline modification | 3.095386e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 3.106126e-3 |
GO:0002076 | osteoblast development | 3.115976e-3 |
GO:0021702 | cerebellar Purkinje cell differentiation | 3.143067e-3 |
GO:0030823 | regulation of cGMP metabolic process | 3.194309e-3 |
GO:0090193 | positive regulation of glomerulus development | 3.225540e-3 |
GO:0021547 | midbrain-hindbrain boundary initiation | 3.241125e-3 |
GO:0021501 | prechordal plate formation | 3.241125e-3 |
GO:0042297 | vocal learning | 3.260443e-3 |
GO:0034227 | tRNA thio-modification | 3.260443e-3 |
GO:0002098 | tRNA wobble uridine modification | 3.260443e-3 |
GO:0043010 | camera-type eye development | 3.267359e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 3.279545e-3 |
GO:0044130 | negative regulation of growth of symbiont in host | 3.300626e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0030488 | tRNA methylation | 1.121286e-15 |
GO:0010565 | regulation of cellular ketone metabolic process | 2.354649e-12 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.467479e-11 |
GO:0051049 | regulation of transport | 1.526393e-11 |
GO:0043269 | regulation of ion transport | 8.563847e-10 |
GO:0009895 | negative regulation of catabolic process | 1.732906e-9 |
GO:0060341 | regulation of cellular localization | 3.118345e-9 |
GO:0070588 | calcium ion transmembrane transport | 3.154181e-9 |
GO:0072595 | maintenance of protein localization to organelle | 3.452567e-9 |
GO:0019217 | regulation of fatty acid metabolic process | 5.347112e-9 |
GO:0033238 | regulation of cellular amine metabolic process | 6.807600e-9 |
GO:0031330 | negative regulation of cellular catabolic process | 8.904047e-9 |
GO:0050995 | negative regulation of lipid catabolic process | 9.322636e-9 |
GO:0006081 | cellular aldehyde metabolic process | 1.016406e-8 |
GO:0003008 | system process | 1.242722e-8 |
GO:0033700 | phospholipid efflux | 1.258294e-8 |
GO:0032369 | negative regulation of lipid transport | 1.490925e-8 |
GO:0006400 | tRNA modification | 1.532504e-8 |
GO:0046092 | deoxycytidine metabolic process | 1.570220e-8 |
GO:0034762 | regulation of transmembrane transport | 1.768362e-8 |
GO:0050994 | regulation of lipid catabolic process | 1.976295e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.585118e-8 |
GO:0034382 | chylomicron remnant clearance | 3.751707e-8 |
GO:0051457 | maintenance of protein location in nucleus | 4.064424e-8 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 4.840275e-8 |
GO:0032368 | regulation of lipid transport | 5.184579e-8 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 5.628950e-8 |
GO:0001510 | RNA methylation | 5.669007e-8 |
GO:0051924 | regulation of calcium ion transport | 6.414978e-8 |
GO:0007586 | digestion | 1.252322e-7 |
GO:0045923 | positive regulation of fatty acid metabolic process | 1.928747e-7 |
GO:0008033 | tRNA processing | 2.085625e-7 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.304442e-7 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.422321e-7 |
GO:0071529 | cementum mineralization | 3.392142e-7 |
GO:0046184 | aldehyde biosynthetic process | 3.442618e-7 |
GO:0034765 | regulation of ion transmembrane transport | 3.564012e-7 |
GO:0051046 | regulation of secretion | 3.819695e-7 |
GO:0006942 | regulation of striated muscle contraction | 4.839396e-7 |
GO:0051047 | positive regulation of secretion | 4.844764e-7 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 6.729437e-7 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.019947e-6 |
GO:0043932 | ossification involved in bone remodeling | 1.032255e-6 |
GO:0010522 | regulation of calcium ion transport into cytosol | 1.312481e-6 |
GO:0032502 | developmental process | 1.581503e-6 |
GO:0016074 | snoRNA metabolic process | 1.584135e-6 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.686904e-6 |
GO:0010959 | regulation of metal ion transport | 1.696245e-6 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.714262e-6 |
GO:0023052 | signaling | 1.723258e-6 |
GO:0071456 | cellular response to hypoxia | 1.838332e-6 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 1.947923e-6 |
GO:0035249 | synaptic transmission, glutamatergic | 2.159352e-6 |
GO:0015780 | nucleotide-sugar transport | 2.277635e-6 |
GO:0002407 | dendritic cell chemotaxis | 2.439502e-6 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 2.457890e-6 |
GO:0055117 | regulation of cardiac muscle contraction | 2.685103e-6 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 2.884202e-6 |
GO:0009132 | nucleoside diphosphate metabolic process | 3.036715e-6 |
GO:0033002 | muscle cell proliferation | 3.115856e-6 |
GO:0007154 | cell communication | 3.257471e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.681422e-6 |
GO:0018022 | peptidyl-lysine methylation | 3.681422e-6 |
GO:0009125 | nucleoside monophosphate catabolic process | 3.746112e-6 |
GO:0032375 | negative regulation of cholesterol transport | 4.103754e-6 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.226701e-6 |
GO:0006117 | acetaldehyde metabolic process | 4.272019e-6 |
GO:0021670 | lateral ventricle development | 4.469951e-6 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 4.484745e-6 |
GO:2000021 | regulation of ion homeostasis | 4.561393e-6 |
GO:0050789 | regulation of biological process | 4.919442e-6 |
GO:0065005 | protein-lipid complex assembly | 5.291356e-6 |
GO:0046939 | nucleotide phosphorylation | 5.453145e-6 |
GO:0045806 | negative regulation of endocytosis | 5.718461e-6 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 5.960170e-6 |
GO:0046889 | positive regulation of lipid biosynthetic process | 5.988925e-6 |
GO:0045576 | mast cell activation | 6.057388e-6 |
GO:0030855 | epithelial cell differentiation | 6.156476e-6 |
GO:0032501 | multicellular organismal process | 6.179843e-6 |
GO:0031000 | response to caffeine | 6.443586e-6 |
GO:0043279 | response to alkaloid | 6.453786e-6 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 6.482442e-6 |
GO:0071248 | cellular response to metal ion | 6.574626e-6 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 6.743154e-6 |
GO:0010907 | positive regulation of glucose metabolic process | 6.966010e-6 |
GO:0045834 | positive regulation of lipid metabolic process | 7.848993e-6 |
GO:0032374 | regulation of cholesterol transport | 7.910516e-6 |
GO:0032891 | negative regulation of organic acid transport | 8.688812e-6 |
GO:0021591 | ventricular system development | 8.715943e-6 |
GO:0031536 | positive regulation of exit from mitosis | 8.858496e-6 |
GO:0070482 | response to oxygen levels | 8.893943e-6 |
GO:0060696 | regulation of phospholipid catabolic process | 9.185924e-6 |
GO:0010452 | histone H3-K36 methylation | 9.847502e-6 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 9.889531e-6 |
GO:0045598 | regulation of fat cell differentiation | 1.044527e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.076068e-5 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.170012e-5 |
GO:0071453 | cellular response to oxygen levels | 1.186469e-5 |
GO:0050708 | regulation of protein secretion | 1.270920e-5 |
GO:0034220 | ion transmembrane transport | 1.461678e-5 |
GO:0044057 | regulation of system process | 1.473890e-5 |
GO:0032409 | regulation of transporter activity | 1.534587e-5 |
GO:0009134 | nucleoside diphosphate catabolic process | 1.574179e-5 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 1.722961e-5 |
GO:0032655 | regulation of interleukin-12 production | 1.818106e-5 |
GO:0007270 | neuron-neuron synaptic transmission | 1.850160e-5 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 1.883653e-5 |
GO:0042559 | pteridine-containing compound biosynthetic process | 1.909502e-5 |
GO:0051901 | positive regulation of mitochondrial depolarization | 2.003001e-5 |
GO:0003254 | regulation of membrane depolarization | 2.013707e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.130392e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.130392e-5 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.156723e-5 |
GO:0031326 | regulation of cellular biosynthetic process | 2.228238e-5 |
GO:0065007 | biological regulation | 2.310196e-5 |
GO:0045055 | regulated secretory pathway | 2.313997e-5 |
GO:0080090 | regulation of primary metabolic process | 2.324563e-5 |
GO:0007613 | memory | 2.361270e-5 |
GO:0009817 | defense response to fungus, incompatible interaction | 2.424610e-5 |
GO:0009214 | cyclic nucleotide catabolic process | 2.537600e-5 |
GO:0032412 | regulation of ion transmembrane transporter activity | 2.542665e-5 |
GO:0031327 | negative regulation of cellular biosynthetic process | 2.590337e-5 |
GO:0051239 | regulation of multicellular organismal process | 2.634587e-5 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 2.643993e-5 |
GO:0071496 | cellular response to external stimulus | 2.709658e-5 |
GO:0009636 | response to toxin | 2.718820e-5 |
GO:0050880 | regulation of blood vessel size | 2.737332e-5 |
GO:0032879 | regulation of localization | 2.765462e-5 |
GO:0055085 | transmembrane transport | 3.018142e-5 |
GO:0006376 | mRNA splice site selection | 3.021456e-5 |
GO:0003018 | vascular process in circulatory system | 3.029545e-5 |
GO:0035150 | regulation of tube size | 3.045574e-5 |
GO:0016579 | protein deubiquitination | 3.047339e-5 |
GO:0001666 | response to hypoxia | 3.147596e-5 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 3.227112e-5 |
GO:0042311 | vasodilation | 3.353087e-5 |
GO:0051764 | actin crosslink formation | 3.372397e-5 |
GO:0009890 | negative regulation of biosynthetic process | 3.392577e-5 |
GO:0048731 | system development | 3.413041e-5 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 3.469427e-5 |
GO:0055017 | cardiac muscle tissue growth | 3.487384e-5 |
GO:0006399 | tRNA metabolic process | 3.703058e-5 |
GO:0046330 | positive regulation of JNK cascade | 3.706758e-5 |
GO:0042177 | negative regulation of protein catabolic process | 3.715275e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 3.751957e-5 |
GO:0009892 | negative regulation of metabolic process | 3.803331e-5 |
GO:0051099 | positive regulation of binding | 3.987385e-5 |
GO:0050794 | regulation of cellular process | 4.002530e-5 |
GO:0019438 | aromatic compound biosynthetic process | 4.230415e-5 |
GO:0014034 | neural crest cell fate commitment | 4.552845e-5 |
GO:0060079 | regulation of excitatory postsynaptic membrane potential | 4.559019e-5 |
GO:0015862 | uridine transport | 4.586718e-5 |
GO:0001832 | blastocyst growth | 4.642790e-5 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 4.806715e-5 |
GO:0044241 | lipid digestion | 4.820167e-5 |
GO:0017157 | regulation of exocytosis | 4.924624e-5 |
GO:0043691 | reverse cholesterol transport | 5.037223e-5 |
GO:0032488 | Cdc42 protein signal transduction | 5.273483e-5 |
GO:0009396 | folic acid-containing compound biosynthetic process | 5.381556e-5 |
GO:0001539 | ciliary or flagellar motility | 5.546511e-5 |
GO:0043587 | tongue morphogenesis | 5.739499e-5 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 5.739499e-5 |
GO:0006109 | regulation of carbohydrate metabolic process | 5.787410e-5 |
GO:0031323 | regulation of cellular metabolic process | 5.794404e-5 |
GO:0060627 | regulation of vesicle-mediated transport | 5.873155e-5 |
GO:0050714 | positive regulation of protein secretion | 5.877954e-5 |
GO:0035725 | sodium ion transmembrane transport | 5.903171e-5 |
GO:0007275 | multicellular organismal development | 5.908620e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 5.991017e-5 |
GO:0007165 | signal transduction | 6.079425e-5 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 6.079430e-5 |
GO:0035887 | aortic smooth muscle cell differentiation | 6.079430e-5 |
GO:0014074 | response to purine-containing compound | 6.203745e-5 |
GO:0015864 | pyrimidine nucleoside transport | 6.315947e-5 |
GO:0050916 | sensory perception of sweet taste | 6.660725e-5 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6.784859e-5 |
GO:0010873 | positive regulation of cholesterol esterification | 6.826219e-5 |
GO:0072531 | pyrimidine-containing compound transmembrane transport | 7.000712e-5 |
GO:0043303 | mast cell degranulation | 7.006319e-5 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 7.550870e-5 |
GO:0009451 | RNA modification | 7.559826e-5 |
GO:0032965 | regulation of collagen biosynthetic process | 7.571374e-5 |
GO:0033013 | tetrapyrrole metabolic process | 7.640130e-5 |
GO:0009889 | regulation of biosynthetic process | 7.756759e-5 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 7.813213e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.824738e-5 |
GO:0008156 | negative regulation of DNA replication | 7.869582e-5 |
GO:0046031 | ADP metabolic process | 7.908986e-5 |
GO:0022898 | regulation of transmembrane transporter activity | 8.349471e-5 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 8.837393e-5 |
GO:0045722 | positive regulation of gluconeogenesis | 8.837393e-5 |
GO:0002718 | regulation of cytokine production involved in immune response | 8.863535e-5 |
GO:0006778 | porphyrin-containing compound metabolic process | 8.909393e-5 |
GO:0043299 | leukocyte degranulation | 9.325870e-5 |
GO:0071169 | establishment of protein localization to chromatin | 9.347612e-5 |
GO:0035865 | cellular response to potassium ion | 9.347612e-5 |
GO:0019047 | provirus integration | 9.347612e-5 |
GO:0034651 | cortisol biosynthetic process | 9.347612e-5 |
GO:0045601 | regulation of endothelial cell differentiation | 9.492020e-5 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 9.592615e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 9.909567e-5 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 1.006385e-4 |
GO:0031328 | positive regulation of cellular biosynthetic process | 1.006442e-4 |
GO:0009891 | positive regulation of biosynthetic process | 1.056861e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.061796e-4 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 1.067885e-4 |
GO:0007610 | behavior | 1.091992e-4 |
GO:0007422 | peripheral nervous system development | 1.108849e-4 |
GO:0090257 | regulation of muscle system process | 1.136719e-4 |
GO:0051051 | negative regulation of transport | 1.145560e-4 |
GO:0015824 | proline transport | 1.145755e-4 |
GO:0035524 | proline transmembrane transport | 1.150351e-4 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.164789e-4 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.164789e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 1.164789e-4 |
GO:0015684 | ferrous iron transport | 1.186406e-4 |
GO:0070201 | regulation of establishment of protein localization | 1.203223e-4 |
GO:0019722 | calcium-mediated signaling | 1.234283e-4 |
GO:0010906 | regulation of glucose metabolic process | 1.237986e-4 |
GO:0070328 | triglyceride homeostasis | 1.254644e-4 |
GO:0009894 | regulation of catabolic process | 1.291043e-4 |
GO:0071407 | cellular response to organic cyclic compound | 1.297252e-4 |
GO:0006739 | NADP metabolic process | 1.317983e-4 |
GO:0014037 | Schwann cell differentiation | 1.319944e-4 |
GO:0048856 | anatomical structure development | 1.327895e-4 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 1.372367e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 1.375831e-4 |
GO:0043414 | macromolecule methylation | 1.428738e-4 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.437296e-4 |
GO:0031324 | negative regulation of cellular metabolic process | 1.466934e-4 |
GO:2000191 | regulation of fatty acid transport | 1.481121e-4 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 1.481834e-4 |
GO:0002274 | myeloid leukocyte activation | 1.505424e-4 |
GO:0060419 | heart growth | 1.535564e-4 |
GO:0014070 | response to organic cyclic compound | 1.565916e-4 |
GO:0070483 | detection of hypoxia | 1.643555e-4 |
GO:0010633 | negative regulation of epithelial cell migration | 1.687072e-4 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.721929e-4 |
GO:0021592 | fourth ventricle development | 1.755546e-4 |
GO:0030154 | cell differentiation | 1.764730e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 1.768755e-4 |
GO:0042255 | ribosome assembly | 1.793762e-4 |
GO:0046186 | acetaldehyde biosynthetic process | 1.887272e-4 |
GO:0044342 | type B pancreatic cell proliferation | 1.887272e-4 |
GO:0055015 | ventricular cardiac muscle cell development | 1.924637e-4 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.937677e-4 |
GO:0001817 | regulation of cytokine production | 1.949918e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.952036e-4 |
GO:0031329 | regulation of cellular catabolic process | 1.975099e-4 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.010657e-4 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 2.046535e-4 |
GO:0048869 | cellular developmental process | 2.060724e-4 |
GO:0031914 | negative regulation of synaptic plasticity | 2.090721e-4 |
GO:0003032 | detection of oxygen | 2.107990e-4 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.126970e-4 |
GO:0046373 | L-arabinose metabolic process | 2.193030e-4 |
GO:0000238 | zygotene | 2.193030e-4 |
GO:0010721 | negative regulation of cell development | 2.224029e-4 |
GO:0010872 | regulation of cholesterol esterification | 2.259334e-4 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 2.271044e-4 |
GO:0007096 | regulation of exit from mitosis | 2.271044e-4 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 2.279691e-4 |
GO:0007611 | learning or memory | 2.286234e-4 |
GO:0060347 | heart trabecula formation | 2.315182e-4 |
GO:0016539 | intein-mediated protein splicing | 2.341651e-4 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 2.388699e-4 |
GO:0032933 | SREBP-mediated signaling pathway | 2.487331e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.487331e-4 |
GO:0042482 | positive regulation of odontogenesis | 2.521882e-4 |
GO:0045906 | negative regulation of vasoconstriction | 2.544888e-4 |
GO:0033344 | cholesterol efflux | 2.587577e-4 |
GO:0003012 | muscle system process | 2.589037e-4 |
GO:0071773 | cellular response to BMP stimulus | 2.627352e-4 |
GO:0060620 | regulation of cholesterol import | 2.627352e-4 |
GO:0040007 | growth | 2.807709e-4 |
GO:0044058 | regulation of digestive system process | 2.959688e-4 |
GO:0002507 | tolerance induction | 2.969141e-4 |
GO:0070646 | protein modification by small protein removal | 3.111402e-4 |
GO:0017085 | response to insecticide | 3.161279e-4 |
GO:0061001 | regulation of dendritic spine morphogenesis | 3.200465e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 3.210673e-4 |
GO:0006241 | CTP biosynthetic process | 3.215499e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.302094e-4 |
GO:0051930 | regulation of sensory perception of pain | 3.312582e-4 |
GO:0006959 | humoral immune response | 3.416625e-4 |
GO:0001833 | inner cell mass cell proliferation | 3.419136e-4 |
GO:0003229 | ventricular cardiac muscle tissue development | 3.461405e-4 |
GO:0046293 | formaldehyde biosynthetic process | 3.518406e-4 |
GO:0007202 | activation of phospholipase C activity | 3.529026e-4 |
GO:0033136 | serine phosphorylation of STAT3 protein | 3.550341e-4 |
GO:0042035 | regulation of cytokine biosynthetic process | 3.558502e-4 |
GO:0001649 | osteoblast differentiation | 3.562098e-4 |
GO:0010595 | positive regulation of endothelial cell migration | 3.637269e-4 |
GO:0003009 | skeletal muscle contraction | 3.718384e-4 |
GO:0033363 | secretory granule organization | 3.721488e-4 |
GO:0033205 | cell cycle cytokinesis | 3.784178e-4 |
GO:0042755 | eating behavior | 3.789607e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 3.806858e-4 |
GO:0061337 | cardiac conduction | 3.814269e-4 |
GO:0060038 | cardiac muscle cell proliferation | 3.814269e-4 |
GO:0000045 | autophagic vacuole assembly | 3.833869e-4 |
GO:0070584 | mitochondrion morphogenesis | 3.860418e-4 |
GO:0045833 | negative regulation of lipid metabolic process | 3.867080e-4 |
GO:0006937 | regulation of muscle contraction | 3.883893e-4 |
GO:0034101 | erythrocyte homeostasis | 4.002665e-4 |
GO:0030814 | regulation of cAMP metabolic process | 4.006584e-4 |
GO:0010863 | positive regulation of phospholipase C activity | 4.034051e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 4.059706e-4 |
GO:0010629 | negative regulation of gene expression | 4.068277e-4 |
GO:0006198 | cAMP catabolic process | 4.068835e-4 |
GO:0031644 | regulation of neurological system process | 4.133001e-4 |
GO:0030817 | regulation of cAMP biosynthetic process | 4.236764e-4 |
GO:0071241 | cellular response to inorganic substance | 4.332910e-4 |
GO:0030431 | sleep | 4.357944e-4 |
GO:0032099 | negative regulation of appetite | 4.424476e-4 |
GO:0060621 | negative regulation of cholesterol import | 4.477829e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 4.499304e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 4.499310e-4 |
GO:0060192 | negative regulation of lipase activity | 4.633649e-4 |
GO:0045600 | positive regulation of fat cell differentiation | 4.723592e-4 |
GO:0008286 | insulin receptor signaling pathway | 4.864410e-4 |
GO:0050890 | cognition | 4.965400e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 5.013184e-4 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 5.037742e-4 |
GO:0006982 | response to lipid hydroperoxide | 5.037742e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 5.047990e-4 |
GO:0034699 | response to luteinizing hormone stimulus | 5.076694e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 5.076694e-4 |
GO:0042558 | pteridine-containing compound metabolic process | 5.123050e-4 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 5.126984e-4 |
GO:0065009 | regulation of molecular function | 5.292367e-4 |
GO:0060078 | regulation of postsynaptic membrane potential | 5.391094e-4 |
GO:0043687 | post-translational protein modification | 5.411717e-4 |
GO:0034695 | response to prostaglandin E stimulus | 5.411717e-4 |
GO:0070169 | positive regulation of biomineral tissue development | 5.442571e-4 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 5.557725e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 5.594953e-4 |
GO:0000245 | spliceosome assembly | 5.610641e-4 |
GO:0048143 | astrocyte activation | 5.660134e-4 |
GO:0060193 | positive regulation of lipase activity | 5.664806e-4 |
GO:0008615 | pyridoxine biosynthetic process | 5.837280e-4 |
GO:0006930 | substrate-dependent cell migration, cell extension | 5.837280e-4 |
GO:0060281 | regulation of oocyte development | 5.852076e-4 |
GO:0060282 | positive regulation of oocyte development | 5.852076e-4 |
GO:0048167 | regulation of synaptic plasticity | 5.923046e-4 |
GO:0032096 | negative regulation of response to food | 6.018095e-4 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 6.050864e-4 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.183262e-4 |
GO:0044246 | regulation of multicellular organismal metabolic process | 6.196546e-4 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 6.306209e-4 |
GO:0051223 | regulation of protein transport | 6.512814e-4 |
GO:0034633 | retinol transport | 6.528227e-4 |
GO:0071622 | regulation of granulocyte chemotaxis | 6.552894e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.558015e-4 |
GO:0021678 | third ventricle development | 6.578542e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 6.578542e-4 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 6.596487e-4 |
GO:0050877 | neurological system process | 6.651607e-4 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 6.669871e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 6.728547e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 6.739763e-4 |
GO:0051489 | regulation of filopodium assembly | 6.740589e-4 |
GO:0006816 | calcium ion transport | 6.817237e-4 |
GO:0051403 | stress-activated MAPK cascade | 6.998185e-4 |
GO:0051586 | positive regulation of dopamine uptake | 7.050966e-4 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 7.050966e-4 |
GO:0006936 | muscle contraction | 7.211634e-4 |
GO:0051900 | regulation of mitochondrial depolarization | 7.224242e-4 |
GO:0007184 | SMAD protein import into nucleus | 7.260640e-4 |
GO:0007517 | muscle organ development | 7.274290e-4 |
GO:0048259 | regulation of receptor-mediated endocytosis | 7.401228e-4 |
GO:0070838 | divalent metal ion transport | 7.590951e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 7.679293e-4 |
GO:0050849 | negative regulation of calcium-mediated signaling | 7.877603e-4 |
GO:0048659 | smooth muscle cell proliferation | 7.882282e-4 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 7.918441e-4 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 8.095466e-4 |
GO:0044093 | positive regulation of molecular function | 8.246572e-4 |
GO:0016126 | sterol biosynthetic process | 8.334574e-4 |
GO:0052200 | response to host defenses | 8.386646e-4 |
GO:0031668 | cellular response to extracellular stimulus | 8.431973e-4 |
GO:0002675 | positive regulation of acute inflammatory response | 8.675686e-4 |
GO:0015804 | neutral amino acid transport | 8.709052e-4 |
GO:0014916 | regulation of lung blood pressure | 8.731393e-4 |
GO:0006695 | cholesterol biosynthetic process | 8.758097e-4 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 8.821219e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 8.821219e-4 |
GO:0003094 | glomerular filtration | 8.821219e-4 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 8.952431e-4 |
GO:0034504 | protein localization to nucleus | 9.121993e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 9.204542e-4 |
GO:0033240 | positive regulation of cellular amine metabolic process | 9.204542e-4 |
GO:0060491 | regulation of cell projection assembly | 9.427402e-4 |
GO:0003013 | circulatory system process | 9.465611e-4 |
GO:0034377 | plasma lipoprotein particle assembly | 9.560150e-4 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 9.560150e-4 |
GO:0050804 | regulation of synaptic transmission | 9.979755e-4 |
GO:0060998 | regulation of dendritic spine development | 1.000978e-3 |
GO:0018023 | peptidyl-lysine trimethylation | 1.014958e-3 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1.034423e-3 |
GO:0006098 | pentose-phosphate shunt | 1.044197e-3 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.066457e-3 |
GO:0046321 | positive regulation of fatty acid oxidation | 1.069976e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 1.089804e-3 |
GO:0072511 | divalent inorganic cation transport | 1.090501e-3 |
GO:0006481 | C-terminal protein methylation | 1.092397e-3 |
GO:0035269 | protein O-linked mannosylation | 1.092397e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.107426e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 1.107721e-3 |
GO:0048518 | positive regulation of biological process | 1.110682e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 1.124320e-3 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.132417e-3 |
GO:0051098 | regulation of binding | 1.137982e-3 |
GO:0007399 | nervous system development | 1.175193e-3 |
GO:0009893 | positive regulation of metabolic process | 1.196715e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.200864e-3 |
GO:0007386 | compartment pattern specification | 1.238633e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 1.238668e-3 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 1.267255e-3 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 1.267255e-3 |
GO:2000664 | positive regulation of interleukin-5 secretion | 1.267255e-3 |
GO:2000667 | positive regulation of interleukin-13 secretion | 1.267255e-3 |
GO:0001806 | type IV hypersensitivity | 1.267255e-3 |
GO:0060374 | mast cell differentiation | 1.267255e-3 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 1.267255e-3 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 1.276719e-3 |
GO:0072220 | metanephric descending thin limb development | 1.324283e-3 |
GO:0072230 | metanephric proximal straight tubule development | 1.324283e-3 |
GO:0072232 | metanephric proximal convoluted tubule segment 2 development | 1.324283e-3 |
GO:0051458 | corticotropin secretion | 1.324283e-3 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 1.324283e-3 |
GO:0035378 | carbon dioxide transmembrane transport | 1.324283e-3 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.324283e-3 |
GO:0016142 | O-glycoside catabolic process | 1.324283e-3 |
GO:0035377 | transepithelial water transport | 1.324283e-3 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.342144e-3 |
GO:0044030 | regulation of DNA methylation | 1.355324e-3 |
GO:0043113 | receptor clustering | 1.364062e-3 |
GO:0045603 | positive regulation of endothelial cell differentiation | 1.372387e-3 |
GO:0048644 | muscle organ morphogenesis | 1.383922e-3 |
GO:0071277 | cellular response to calcium ion | 1.412236e-3 |
GO:0050709 | negative regulation of protein secretion | 1.459569e-3 |
GO:0060155 | platelet dense granule organization | 1.471678e-3 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.471678e-3 |
GO:0001867 | complement activation, lectin pathway | 1.473030e-3 |
GO:0034380 | high-density lipoprotein particle assembly | 1.497121e-3 |
GO:0032526 | response to retinoic acid | 1.504031e-3 |
GO:0050765 | negative regulation of phagocytosis | 1.505795e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.506993e-3 |
GO:0001503 | ossification | 1.515802e-3 |
GO:0043583 | ear development | 1.516588e-3 |
GO:0051135 | positive regulation of NK T cell activation | 1.526085e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.562429e-3 |
GO:0048738 | cardiac muscle tissue development | 1.570209e-3 |
GO:0006756 | AMP phosphorylation | 1.591035e-3 |
GO:0050823 | peptide antigen stabilization | 1.591035e-3 |
GO:0032342 | aldosterone biosynthetic process | 1.591035e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.591035e-3 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.591035e-3 |
GO:0002508 | central tolerance induction | 1.591035e-3 |
GO:0030501 | positive regulation of bone mineralization | 1.636363e-3 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 1.642399e-3 |
GO:0007267 | cell-cell signaling | 1.650281e-3 |
GO:0061035 | regulation of cartilage development | 1.657488e-3 |
GO:0046415 | urate metabolic process | 1.669201e-3 |
GO:0001969 | regulation of activation of membrane attack complex | 1.669748e-3 |
GO:0018193 | peptidyl-amino acid modification | 1.682612e-3 |
GO:0032649 | regulation of interferon-gamma production | 1.686818e-3 |
GO:0050771 | negative regulation of axonogenesis | 1.688469e-3 |
GO:0032615 | interleukin-12 production | 1.722193e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 1.722193e-3 |
GO:0048535 | lymph node development | 1.724416e-3 |
GO:0019222 | regulation of metabolic process | 1.728374e-3 |
GO:0048144 | fibroblast proliferation | 1.744708e-3 |
GO:0031325 | positive regulation of cellular metabolic process | 1.780037e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.807271e-3 |
GO:0051050 | positive regulation of transport | 1.834737e-3 |
GO:0003015 | heart process | 1.851583e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.851635e-3 |
GO:0010887 | negative regulation of cholesterol storage | 1.872885e-3 |
GO:0060976 | coronary vasculature development | 1.878357e-3 |
GO:0032863 | activation of Rac GTPase activity | 1.897539e-3 |
GO:0010954 | positive regulation of protein processing | 1.897539e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.897539e-3 |
GO:0009236 | cobalamin biosynthetic process | 1.902027e-3 |
GO:0033120 | positive regulation of RNA splicing | 1.911061e-3 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 1.918977e-3 |
GO:0046320 | regulation of fatty acid oxidation | 1.928883e-3 |
GO:0006111 | regulation of gluconeogenesis | 1.988903e-3 |
GO:0046928 | regulation of neurotransmitter secretion | 1.995695e-3 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 2.047899e-3 |
GO:0051899 | membrane depolarization | 2.052164e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 2.073737e-3 |
GO:0007440 | foregut morphogenesis | 2.125118e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 2.135198e-3 |
GO:0031508 | centromeric heterochromatin formation | 2.135198e-3 |
GO:0032890 | regulation of organic acid transport | 2.147066e-3 |
GO:0050729 | positive regulation of inflammatory response | 2.153247e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 2.189572e-3 |
GO:0050881 | musculoskeletal movement | 2.196139e-3 |